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balhimycin biosynthesis. Purified N-terminally His-tagged 
Bbr shows specific DNA-binding to five promoter regions 
within the gene cluster. By in silico analysis and by compari-
son of the DNA sequences binding Bbr, conserved inverted 
repeat sequences for the Bbr-binding site are proposed. The 
putative Bbr consensus sequence differs from that pub-
lished for StrR. 
 
Copyright © 2007 S. Karger AG, Basel 
 Introduction 
 The vancomycin-type glycopeptides are the drugs of 
last resort for the treatment of severe infections caused by 
antibiotic-resistant Gram-positive bacteria, in particular 
by methicillin-resistant staphylococci and penicillin-re-
sistant enterococci [Yao and Crandall, 1994]. Balhimycin 
( fig. 1 b), a vancomycin-like glycopeptide antibiotic which 
is synthesized by  Amycolatopsis balhimycina (formerly 
 Amycolatopsis mediterranei ) DSM5908 [Nadkarni et al., 
1994; Wink et al., 2003], shares the same heptapeptide 
aglycon as vancomycin ( fig. 1 a), but differs in the glyco-
sylation pattern. The activity of glycopeptide antibiotics 
against a wide range of Gram-positive bacteria arises 
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 Abstract 
 Balhimycin, produced by the actinomycete  Amycolatopsis 
balhimycina DSM5908, is a glycopeptide antibiotic highly 
similar to vancomycin, the antibiotic of ‘last resort’ used for 
the treatment of resistant Gram-positive pathogenic bacte-
ria. Partial sequence of the balhimycin biosynthesis gene 
cluster was previously reported. In this work, cosmids which 
overlap the region of the characterized gene cluster were 
isolated and sequenced. At the ‘left’ end of the cluster, genes 
were identified which are involved in balhimycin biosynthe-
sis, transport, resistance and regulation. The ‘right’ end bor-
der is defined by a putative 3-deoxy- D -arabino-heptu-
losonate 7-phosphate synthase  (dahp) gene. The proximate 
gene is similar to a type I polyketide synthase gene of the 
rifamycin producer  Amycolatopsis mediterranei indicating 
that another biosynthesis gene cluster might be located di-
rectly next to the balhimycin gene cluster. The newly identi-
fied StrR-like pathway-specific regulator, Bbr, was character-
ized to be a DNA-binding protein and may have a role in 
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from their ability to bind to the terminal  D -alanyl- D -ala-
nine ( D -Ala- D -Ala) dipeptide of bacterial cell wall pre-
cursors [Williams and Bardsley, 1999].
 Recent advances in the investigation of balhimycin 
biosynthesis by means of genetics and biochemistry, as 
well as analytical chemistry of the pathway intermedi-
ates, rendered an understanding of the central steps of the 
glycopeptide biosynthesis (as reviewed by Stegmann et al. 
[2005]). Starting with the supply of the non-proteinogen-
ic amino acid precursors, followed by the assembly of the 
heptapeptide scaffold, and finally by a series of modify-
ing reactions, balhimycin displays a great structural com-
plexity. All genes required for its biosynthesis are clus-
tered [Pelzer et al., 1999; Recktenwald et al., 2002].
 However, comparison with other glycopeptide biosyn-
thesis gene clusters coding for chloroeremomycin [van 
Wageningen et al., 1998], teicoplanin [Li et al., 2004; So-
sio et al., 2004], dalbavancin [Sosio et al., 2003], comple-
statin [Chiu et al., 2001] and A47934 [Pootoolal et al., 
2002] revealed that resistance, transport and regulatory 
genes are still missing from the sequence of the balhimy-
cin biosynthesis gene cluster determined so far.
 In particular, the identification and characterization 
of regulatory genes is crucial for understanding the mech-
anism by which complex biosynthetic steps are coordi-
nated and for genetically manipulating the producing 
strains to enhance antibiotic production.
 Regulation of secondary metabolism is governed 
mainly by pathway-specific regulators. Many of the path-
way-specific regulatory proteins that control secondary 
metabolism in streptomycetes belong to the SARP ( Strep-
tomyces antibiotic regulatory proteins) family. These 
transcriptional activators contain a winged helix-turn-
helix (HTH) motif towards their N-termini that is also 
found in the OmpR family of proteins and at least some 
of the SARPs appear to recognize direct heptameric re-
peats within the promoter regions of the genes that they 
regulate [Wietzorrek and Bibb, 1997]. SARPs include Ac-
tII-ORF4 from  Streptomyces coelicolor A3(2), DnrI from 
 Streptomyces peucetius , which regulate the production of 
the polyketide antibiotics actinorhodin and daunorubi-
cin, respectively, RedD from  S. coelicolor A3(2), which 
controls synthesis of the tri-pyrolle undecylprodigiosin, 
and AfsR, a pleiotropic regulatory protein for antibiotic 
production in  S. coelicolor A3(2) [Arias et al., 1999; Shel-
don et al., 2002; Wietzorrek and Bibb, 1997].
 Besides SARPs, other types of pathway-specific regu-



































































 Fig. 1. Structures of vancomycin-type gly-
copeptide antibiotics.  a Vancomycin ( A. 
orientalis C3294).  b Balhimycin  (A. balhi-
mycina) . The aromatic rings (AB, C- O -D, 
D- O -E) of balhimycin are assigned. 
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strains: such as SrmR of the spiramycin cluster in  Strep-
tomyces ambofaciens , which shows no significant se-
quence similarity to any other known regulatory protein; 
MmyR of the methylenomycin cluster in  S. coelicolor , rep-
resenting the first example of a negative pathway-specif-
ic regulator of antibiotic production [as reviewed by 
Chater and Bibb, 1997], PrpA of the phosphinothricin 
tripeptide cluster in  Streptomyces viridochromogenes 
[Schwartz et al., 2004], BrpA and DnrN regulators for bi-
alaphos production in  Streptomyces hygroscopicus  and for 
daunorubicin production in  Streptomyces peucetius,  re-
spectively, which are similar to two-component response 
regulators [as reviewed by Chater and Bibb, 1997] and 
TylP from  Streptomyces fradiae  which negatively regu-
lates tylosin production [Stratigopoulos et al., 2002] and 
is homologous to   -butyrolactone-binding proteins.
 Another type of regulator is exemplified by StrR, the 
pathway-specific activator protein in  Streptomyces gri-
seus [Retzlaff and Distler, 1995] and  Streptomyces glau-
sescens [Beyer et al., 1996]. It activates the expression of 
streptomycin biosynthetic genes by binding to several 
promoter regions. Based on seven specific binding sites, 
a consensus sequence GTTCGActG(N) 11 CagTcGAAC 
[Retzlaff and Distler, 1995] was deduced. Transcription 
of all the streptomycin biosynthesis genes apart from the 
resistant gene is dependent on StrR as shown by Tomono 
et al. [2005]. StrR has a putative HTH motif in the central 
region of its primary structure [Retzlaff and Distler, 
1995]. Homologs of  strR have been found in aminocou-
marin, aminoglycoside and glycopeptide antibiotic bio-
synthetic gene clusters.
 In this report, we determined further sequence of the 
balhimycin biosynthetic gene cluster and thereby identi-
fied besides others a regulatory gene. We characterized 
the StrR-like pathway-specific regulator, Bbr, in order to 
determine its role in balhimycin biosynthesis.
 Results 
 Completion of the Balhimycin Biosynthesis Gene 
Cluster and Analysis of the Newly Identified Open 
Reading Frames (ORFs) 
 The major part of the balhimycin biosynthesis gene 
cluster has been identified, sequenced and characterized 
as shown by Pelzer et al. [1999] and Recktenwald et al. 
[2002]. After assigning functions to all identified genes 
and proposing the biosynthetic pathway for balhimycin, 
two questions remained open: Since no regulatory gene 
was found so far, how is the expression of these complex 
biosynthetic steps coordinated? Where are the borders of 
the balhimycin biosynthesis gene cluster?
 In order to find adjacent cosmids overlapping with the 
previously identified cluster sequence on the ‘left’ border 
and to define the borders of the balhimycin biosynthesis 
gene cluster, an appropriate DNA probe for hybridization 
against available cosmid pools of the balhimycin producer 
was designed. To avoid cross-hybridization, primers were 
designed (primer Ris1 and Ris2;  table 1 ) from a non-con-
served area of the  bpsA gene, encoding a non-ribosomal 
peptide synthetase (NRPS). Through Southern hybridiza-
tion as well as direct polymerase chain reaction (PCR) 
screening of cosmid pools, we isolated two adjacent cos-
mids, 4.3 and 55.1 (see  table 2 ). Numerous  Pst I and  Eco RI 
fragments of these new cosmids were cloned and se-
quenced. The new sequence overlaps with the upstream 
region of the NRPS gene  bpsA and encodes gene products 
with significant homology to an ABC transporter (Tba), a 
prephenate dehydrogenase (Pdh), a StrR-homologous reg-
ulator (Bbr), a VanY-type carboxypepditase (VanY), a two-
component system response regulator (VanR), and a two-
component system sensor kinase (VanS) (see  table 3 and 
 fig. 5 ). Cosmid 55.1 carries only 751 bp of the  vanS gene.
 In order to define the right border of the balhimycin 
biosynthesis gene cluster, Cosmid 16.1 (see  table 1 ), which 
has been partially sequenced previously and contains a 
major part of the sequenced balhimycin biosynthesis 
gene cluster, was further sequenced and analyzed. This 
resulted in the identification of a new gene  dahp  (see 
 fig. 5 ) , the product of which is significantly similar to a 
3-deoxy- D -arabino-heptulosonate 7-phosphate (DAHP) 
synthase from  Amycolatopsis  methanolica ( table 3 ).
 Downstream of  dahp,  a gene which encodes for a pro-
tein with 40% identity on amino acid level to a type I 
polyketide synthase of the rifamycin producer  A. medi-
terranei, was found, indicating that this gene is not part 
of the balhimycin biosynthesis gene cluster.
 Two Regulatory Genes Are Present in the Balhimycin 
Biosynthesis Gene Cluster 
 From the analysis described above, two regulatory 
genes were identified in the balhimycin biosynthesis gene 
cluster.
 One of the regulatory proteins, VanR, consists of 225 
amino acids and is significantly similar to putative two-
component system response regulators with highest ho-
mology to the putative two-component system response 
regulator from  S. coelicolor A3(2) ( table 3 ) and may be 
involved in resistance: VanR homologs are present in re-
sistant pathogenic bacteria [Arthur and Courvalin, 1993] 
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and a  S. coelicolor homolog is induced by various glyco-
peptide antibiotics [Hutchings et al., 2006].
 The second regulatory protein, Bbr, consists of 321 
amino acids and shows significant similarity to putative 
transcriptional activators with 47% identity on an amino 
acid level (over a length of 289 amino acids) to StrR, the 
well-characterized pathway-specific regulator for strep-
tomycin biosynthesis, in  S. glaucescens [Beyer et al., 1996] 
and  S. griseus [Distler et al., 1987]. Bbr shows the charac-
teristic HTH motif commonly found in DNA-binding 
regulatory proteins. The HTH motif is located from ami-
no acid 183 to 204 of Bbr (based on HTH prediction by 
the Dodd-Egan method [Dodd and Egan, 1990]).
 In silico Approaches to Determine Bbr-Binding Sites 
within the Balhimycin Biosynthetic Gene Cluster 
 Based on the previously published palindromic se-
quence of StrR-binding site [Retzlaff and Distler, 1995] 
GTTCGActG(N) 11 CagTcGAAC, in silico nucleotide se-
quence analysis was carried out to find inverted repeat 
sequences within the balhimycin biosynthetic gene clus-
ter which might be targets for Bbr binding. However, an 
identical palindromic sequence could not be identified. 
Applying PatScan software, the sequence available for the 
balhimycin biosynthetic gene cluster was scanned in or-
der to identify inverted repeat sequences allowing mis-
matches and various lengths of non-conserved spacers. 
Table 1. List of primers used for this study. The names of the primers are indicated on the left. The primer sequence is 5 to 3
Primers used for detection of adjacent cosmids Primers used for Bbr purification
Ris 1;CAAGGCTGAGTTCGACGACGATTCC bbrHIS1;GGAGATCTGCCGCAAAGTTGACGAAGTAGATCC
Ris 2;ACTGCCGTTTCTGCAACTCCGCCAG bbrHIS2;GGAGATCTCCGTGGTCACGCGATCATC
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Alignment of the inverted repeat sequences found in pu-
tative promoter regions revealed the presence of a con-
served palindromic motive in the upstream regions of 
 bbr ,  tba ,  oxyA ,  dvaA and  orf7 with one base pair mis-
match, and in the upstream region of  dpgA with two base 
pairs mismatch ( fig. 2 ). 
 Overexpression of bbr in Escherichia coli and 
Purification of the Protein by Affinity Chromatography 
 To determine whether Bbr is a DNA-binding protein 
and whether the predicted in silico DNA-binding sites 
within the balhimycin biosynthetic gene cluster are true 
targets, Bbr was first overexpressed in E. coli and puri-
fied.
 bbr from  A. balhimycina was amplified by PCR with 
the corresponding primers (see  table 1 ), cloned and ex-
pressed in  E. coli under the control of the T7 promoter 
using the vector pRSETB. The N-terminal His 6 -tagged 
Bbr was purified using nickel affinity chromatography. 
The apparent molecular weight of Bbr is about 37 kDa 
(calculated mass 35.324 kDa) as determined by SDS-
PAGE analysis ( fig. 3 ). Partially purified Bbr which was 
Strain or plasmid Relevant features Source or reference
Strains
E. coli XL1-Blue General cloning host Bullock et al., 1987
A. balhimycina 
DSM5908 Balhimycin-producing wild type Nadkarni et al., 1994
Plasmids
pSP1 Gene disruption vector; Eryr Pelzer et al., 1997
pJOE890 Amr Altenbuchner et al., 1992
Cosmid 16.1 Contains part of the balhimycin 
biosynthetic gene cluster
Recktenwald et al., 2002
Cosmid 55.1 Contains part of the balhimycin 
biosynthetic gene cluster
This work
Cosmid 4.3 Contains part of the balhimycin 
biosynthetic gene cluster
This work
Eryr = Erythromycin-resistant; Amr = ampicillin-resistant.
Table 3. ORFs identified in this study and their proposed function
ORFs Size (aa) % aa identity Similarities to functionally characterized proteins/
UNIPROT-Acc
Proposed function








VanY 206 31% over 143 aa VanYB-carboxypeptidase in Enterococcus faecalis 
plasmid pIP834/Q9L8Y3
VanY-type carboxypeptidase 
Bbr 321 47% over 289 aa StrR, pathway-specific regulator for streptomycin biosyn-
thesis, in S. glaucescens/Q54267 and S. griseus/Q53ID1
StrR family transcriptional 
regulator
Pdh 291 31% over 274 aa cyclohexadienyl dehydrogenase (prephenate 
dehydrogenase) in Zymomonas mobilis/Q04983
prephenate dehydrogenase




Dahp 365 60% over 348 aa DAHP synthase in A. methanolica/Q6TZ04 DAHP synthase
Table 2. Bacterial strains and plasmids 
used for this study
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eluted with 200 and 500 m M imidazole ( fig. 3, lanes 5 + 
6) was used for gel retardation analysis. The protein yield 
of these fractions was about 0.2 mg/ml.
 Bbr Has DNA-Binding Activity and Targets Several 
Promoter Regions of the Balhimycin Biosynthetic 
Gene Cluster 
 The purified His 6 -tagged Bbr was used to determine 
the DNA-binding activity of Bbr by gel retardation as-
says. Digoxygenin (DIG)-labeled DNA fragments (100–
200 bp upstream of predicted start codons) amplified via 
PCR from all upstream regions of coding sequences with-
in the balhimycin biosynthetic gene cluster were used as 
probes.
 The specificity of Bbr binding was confirmed by con-
trols using 10- and/or 100-fold unlabeled competitor 
DNA of the corresponding probes as well as non-specific 
 Streptomyces plasmid DNA. Unlabeled DNA fragments 
of the investigated putative promoter regions compete 
with the corresponding DIG probes for binding to His 6 -
tagged Bbr, whereas there is no competition in case of the 
non-specific  Streptomyces DNA. In one case the protein 
was boiled for 10 min prior to incubation with the  bbr 
probe thus denaturing Bbr and affecting its binding to 
the DNA probe ( fig. 4 a).
 Analysis of gel retardation assays revealed that Bbr 
specifically binds to the upstream regions of the regula-
tor gene  bbr , the putative ABC transporter gene  tba , the 
P450 monooxygenase gene  oxyA , a gene involved in the 
dehydrovancosamine synthesis dvaA , and the putative 
sodium-proton anti-porter gene  orf7 ( fig. 4 a,  5 ). No 
binding was observed to the upstream regions of the 
ecneuqes susnesnoc RrtS CAAGcTgaC NNNNNNNNNNN GtcAGCTTG
 9 9 11
6 671
AACCTG            tba GTG CC AG GAA GC CGTTC CAGGTT
ACCTG            Ayxo G CC GC CT A GCA GC AG CG CAGGTTG
CCAACCTG             rbb ACC AG TCGG G GA CA CAGGTTG
CCAACCTG            7fro ACG AG TGG GC T C- A CAGGTTG
CCAACCTG            Aavd GCG AG TTA GC C C- G TG C CAGG
ecneuqes susnesnoc rbB CAGGtTgNcNNGcNNNAgNCNccaACCTG
a
b CCTGAgpd G TT CCGCAGGAAGTGGCGCA A C CAG
c
 Fig. 2. Consensus sequence of potential 
Bbr-binding sites identified by in silico 
analysis.  a CLUSTAL W (1.60) multiple 
 sequence alignment showing positive 
PatScan hits. On the left are the genes 
where the consensus sequence indicated 
under  c was identified in the promoter re-
gion. Arrows correspond to inverted re-
peats, double arrows to the number of 
spacing. Bbr binds to the promoter region 
of these five genes.  b Sequence of the up-
stream region of  dpgA with two mismatch-
es. Here Bbr does not bind.  c Consensus 









 Fig. 3. Overexpression and partial purification of Bbr in  E. coli . 
SDS-PAGE showing purification of N-terminal His(6)-tagged 
Bbr by nickel-affinity chromatography. Numbers of lanes corre-
spond to purification steps as follows: 1: insoluble fraction of 
crude extract, 2: soluble fraction of crude extract, 3: flow through 
Ni-NTA column (Qiagen), 4: washing with buffer, 5: elution with 
200 m M imidazole, 6: elution with 500 m M imidazole. M stands 
for protein size marker. Molecular weights are denoted on the left 
in kDa. Arrow corresponds to purified soluble Bbr. 
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NRPS genes  bpsA and  bpsC , the P450 monooxygenase 
genes  oxyB and  oxyC , the halogenase gene  bhaA , the gly-
cosyltransferase genes  bgtfA and  bgtfC , a gene involved 
in the biosynthesis of the dehydrovancosamine sugar 
dvaC , a gene with unknown function  orf2 , the methyl-
transferase gene  bmt , the hydrolase gene  bhp , the hy-
droxymandelate synthase gene  hmaS , the dihydroxy-
phenylglycine synthase gene  dpgA , and the DAHP syn-
thase gene  dahp (only one representative example of 
these results is shown in  figure 4 b; summary of results 
in  figure 5 ).
 Analysis of bbr Expression in Relation to Balhimycin 
Production  
 The temporal transcription pattern of  bbr and of some 
biosynthetic genes ( oxyA ,  bhp and  bhaA ) was analyzed in 
correlation to antibiotic production using reverse tran-
scription (RT)-PCR. The onset of antibiotic production 
was 35 h after incubation assessed by bioassay.
 RNA was isolated at different time points ( fig. 6 ) using 
the RNA isolation kit (Qiagen) and used to produce the 
corresponding cDNA. PCR was carried out using cDNA 
as template and the primers listed in  table 1 . The gene en-

































 Fig. 4. Gel retardation assays with partially purified Bbr and DIG-labeled PCR fragments.  a The investigated 
promoter regions are denoted on top of each assay. Lanes are marked as follows: – = DIG-labeled PCR fragment; 
+ = DIG-labeled PCR fragment with purified His 6 -Bbr;  Cold = unlabeled PCR fragment corresponding to each 
promoter region + DIG-labeled PCR fragment + purified His-Bbr;  Non specific = unlabeled non-specific  Strep-
tomyces DNA + DIG-labeled PCR fragment + purified His-Bbr. Arrows indicate shifts corresponding to DNA-
protein complex.  b One example of gel retardation assay ( pdh ) where no binding was observed between Bbr and 
the DIG-labeled DNA fragment. Rest of data for negative results is not shown. Lanes as described under  a . 
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bbr pdh tba bpsA
vanS vanR vanY
bpsB
bpsC orf1 oxyA oxyB oxyC bhaA
bgtfA bgtfB bgtfC dvaC orf2 bmt pgat bhp bpsD oxyD
dvaE



































 Fig. 5. Genetic organization of the balhimycin biosynthesis gene cluster and summary of Bbr binding.  a Pre-
dicted open reading frames (ORFs) are indicated by arrows. Gene names are indicated underneath the corre-
sponding ORFs. Functions of genes are listed on the right. Bar on the left is proportional to 1 kb. New  orfs iden-
tified in this study are  vanS , vanR ,  vanY ,  bbr ,  pdh ,  tba and  dahp and are underlined. The  vanS gene is uncom-
pleted (dashed line). B denotes promoter regions where Bbr-DNA complex was observed; N denotes DNA 
regions where no binding of Bbr was observed; shaded squares show experimentally revealed co-transcribed 


































 Fig. 6. Reverse transcriptase PCR experi-
ments of  bbr and some biosynthesis genes. 
The gene names are indicated on the right. 
hrdB  is the major sigma factor of  A. balhi-
mycina  WT. The amplified fragments were 
separated on agarose gel. M stands for 
DNA marker. Time points of RNA isola-
tion are indicated on the top. A 500-bp 
marker is indicated on the left. Template 
used for each gene in brackets is indicated 
on the far left. As template cDNA was 
used. 
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was used as a positive control since it is constitutively ex-
pressed throughout growth [Puk, unpubl. data]. Negative 
controls were carried out under the same conditions us-
ing the isolated RNA as a template without reverse tran-
scriptase. The RT-PCR experiments showed that the ex-
pression of  bbr occurs simultaneously with that of the 
studied biosynthetic genes starting at least 8 h before the 
onset of antibiotic production ( fig. 6 ).
 Discussion 
 Seven New Genes Have Been Identified in the 
Balhimycin Biosynthetic Gene Cluster 
 In this work the sequence of the balhimycin biosyn-
thetic gene cluster was extended. The newly identified 
genes,  tba ,  pdh ,  dahp ,  vanY ,  vanS and two regulatory 
genes,  bbr and  vanR , are expected to be involved in the 
biosynthesis, resistance or regulation of balhimycin.
 pdh and  dahp , the products of which are highly similar 
to prephenate dehydrogenases and DAHP synthases, re-
spectively, might represent a link between primary and 
secondary metabolism through the shikimate-choris-
mate biosynthetic pathway and are most likely needed for 
the supply of hydroxyphenylpyruvate, a precursor which 
is required for the biosynthesis of the balhimycin non-
proteinogenic amino acids. Tba is probably involved in 
balhimycin transport, since it is highly similar to trans-
membrane ABC (ATP-binding cassette) transporters. 
VanY may be involved in resistance, since it is highly sim-
ilar to  D,D -carboxypeptidases which contribute to vanco-
mycin resistance by hydrolyzing the C-terminal  D -Ala 
residue of peptidoglycan precursors [Arthur and Cour-
valin, 1993]. The VanS-VanR putative two-component 
regulatory system identified in our study may also be in-
volved in conferring resistance to the balhimycin pro-
ducer in a manner similar to the well-established vanco-
mycin resistance cascade in pathogenic enterococci [Ar-
thur et al., 1992] and in the non-pathogen  S. coelicolor 
[Hutchings et al., 2006].
 From this study and combining previous sequence re-
ports, a total of 66 kb sequence data was determined for 
the balhimycin biosynthetic gene cluster encoding 36 
ORFs. One border of the balhimycin biosynthetic gene 
cluster has also been predicted. Sequence analysis of the 
right border downstream of  dahp revealed a type I 
polyketide synthase of a rifamycin producer in  A. medi-
terranei which could be part of another biosynthetic gene 
cluster located directly next to the balhimycin biosynthe-
sis locus.
 The  vanR and  vanS genes identified in this study are 
most likely to be part of the balhimycin biosynthetic gene 
cluster, since their homologs are located within the other 
glycopeptide gene clusters such as chloroeremomycin, 
dalbavancin, complestatin and teicoplanin gene clusters 
[Donadio et al., 2005]. Nevertheless, to determine the fi-
nal definition of the left border of the balhimycin biosyn-
thetic gene cluster, further sequencing of the area up-
stream of  vanS is underway. 
 Bbr Binds Directly to the Promoter Region of the 
Balhimycin Biosynthesis Genes  
 Bbr, a StrR-like pathway-specific regulator, was identi-
fied and characterized in this study to determine a pos-
sible role in balhimycin biosynthesis. Functional studies 
of StrR like regulators have been limited to StrR [Beyer et 
al., 1996; Retzlaff and Distler, 1995], KasT from the kasu-
gamycin producer  Streptomyces kasugaensis [Ikeno et al., 
2002] and NovG from the novobiocin producer  Strepto-
myces spheroides [Eustaquio et al., 2005]. Our DNA-bind-
ing studies with Bbr provide the first characterization of 
a regulator of biosynthesis genes for glycopeptide antibi-
otics. On amino acid level, Bbr is as similar to KasT and 
NovG (45% amino acid identity) as it is to StrR.
 The putative NovG-binding site possesses a conserved 
palindromic structure with the sequence GTTCAA-
CTG(N) 11 CRGTTGAAC, as determined recently by gel 
retardation analysis [Eustaquio et al., 2005], which differs 
in two positions from the StrR-binding site consensus se-
quence [Retzlaff and Distler, 1995]. Identical inverted re-
peat sequences could not be identified within the balhi-
mycin biosynthetic gene cluster. Sequence-specific bind-
ing of Bbr to five putative promoter regions in the gene 
cluster allowed the deduction of a StrR-related palin-
dromic consensus sequence, GTCCAa(N) 17 TtG GAC. 
Even a mismatch by two bases abolishes the binding abil-
ity of Bbr experimentally as was shown for the inverted 
repeat sequence upstream of  dpgA which was detected by 
in silico analysis.
 Interestingly, the proposed palindromic sequence for 
Bbr-binding site is also conserved within other glycopep-
tide biosynthetic gene clusters [Donadio et al., 2005]. 
Comparison of the balhimycin biosynthetic gene cluster 
with the biosynthetic gene clusters of chloroeremomycin 
(cep), dalbavancin (dbv), A47934 (sta) and teicoplanin 
(tcp) revealed the presence of the suggested Bbr consen-
sus sequence in the upstream region of the biosynthetic 
gene  oxyA , the product of which is significantly homolo-
gous to P450 monooxygenases, in all five clusters. In ad-
dition, the same consensus sequence is found upstream 
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of the gene encoding the StrR homologous regulator in 
cep, upstream of the response regulatory gene in tcp, up-
stream of a gene unique for dalbavancin biosynthesis and 
upstream of a homolog to bal  orf2 from tcp [Donadio et 
al., 2005]. Furthermore, we have newly identified the Bbr 
consensus sequence upstream of the ABC transporter in 
sta and dbv clusters. 
 Operon Structures within the Balhimycin Biosynthetic 
Gene Cluster 
 Bbr binds upstream of  bbr ,  tba ,  oxyA ,  orf7 and  dvaA . 
Combining these results together with our previous re-
ports on possible operon structures within the balhimy-
cin biosynthetic gene cluster [Pfeifer et al., 2001; Puk et 
al., 2004] and with sequence analysis data, the following 
operon structures can be suggested for the balhimycin 
biosynthetic gene cluster ( fig. 5 ): the first operon com-
prises  bbr and  pdh ; the second operon comprises  tba and 
all three NRPS genes together with the small  orf1; the 
third operon covers the region from  oxyA to  bmt ; the 
fourth operon only consists of the divergent gene  pgat; 
the fifth operon comprises the genes involved in the bio-
synthesis of   -hydroxytyrosine,  bhp ,  bpsD and  oxyD 
[Puk et al., 2004], as well as genes of the hydroxyphenyl-
glycine biosynthesis,  hmaS and  hmO ; the sixth operon 
contains only  orf7 , and the last operon expands from 
 dvaA to  dahp . As mentioned above, the proposal of these 
operon structures within the balhimycin biosynthetic 
gene cluster is based on either experimental data or se-
quence analysis revealing that the start (GTG) and stop 
(TGA) codons of the genes overlap with the sequence 
GTGA suggesting that these genes are most likely trans-
lationally coupled. All other intergenic regions were not 
targeted by the pathway-specific regulator Bbr. This im-
plies that the respective genes are either co-transcribed 
with upstream genes, which are targeted by Bbr, or reg-
ulated via a different mechanism which has not yet been 
characterized.
 The divergent genes at the core of the balhimycin bio-
synthetic gene cluster suggest that the intergenic region 
between  bhp and  pgat might contain a promoter. How-
ever, the proposed palindromic sequence for Bbr-binding 
site could not be identified within this intergenic region 
and no binding of Bbr was observed in gel retardation as-
says. The fact that Bbr does not bind to the promoter re-
gion of  bhp - pgat , genes which are involved in the biosyn-
thesis of balhimycin precursors, leads to the assumption 
that these genes are regulated via a different mechanism 
which is still elusive.
 Concluding Remarks 
 The putative two-component regulatory system genes 
 vanR and  vanS identified in our study may be part of a 
resistance cascade similar to that of vancomycin [Arthur 
et al., 1992]. As Bbr did not bind to the promoter regions 
of either gene, it seems likely that resistance is controlled 
separately from the biosynthesis. Induction of resistance 
might be achieved through sensing the glycopeptide an-
tibiotic by the histidine kinase VanS in analogy to the role 
of VanS in  S. coelicolor [Hutchings et al., 2006].
 In  S. griseus , the molecular mechanism by which a   -
butyrolactone microbial hormone, A-factor, triggers 
streptomycin biosynthesis is well established. A tran-
scriptional activator AdpA switches on many genes re-
quired for both morphological development and second-
ary metabolism. AdpA binds to the promoter region of 
 strR  and activates its transcription. The pathway-specific 
transcriptional activator StrR then induces transcription 
of the streptomycin biosynthetic genes by binding mul-
tiple sites in the gene cluster, thus leading to biosynthesis 
of streptomycin [reviewed by Horinouchi, 2002; Tomono 
et al., 2005]. Whether balhimycin production is triggered 
by a similar regulatory cascade and the transcription of 
 bbr is induced by an AdpA-equivalent activator still needs 
to be investigated.
 Ongoing studies of the complex regulation of balhi-
mycin production will deliver a comprehensive picture of 
the overall antibiotic biosynthesis. This will aid in the 
genetic manipulation of the biosynthetic gene cluster and 
will help obtain new compounds to combat the sharply 
increasing antibiotic resistance.
 Experimental Procedures 
 Bacterial Strains and Plasmids 
 The strains and plasmids used for this study are listed in 
 table 2 .
 Media and Culture Conditions 
 E. coli strains were grown in Luria broth medium [Sambrook 
et al., 1989] supplemented with 100   g of ampicillin ml –1  or 
100   g of apramycin ml –1  when necessary to maintain plasmids. 
 A. balhimycina  strains were grown in R5 medium [Kieser et al., 
2000] at 30  °  C. Liquid and solid media were supplemented with 
50   g ml –1  of apramycin to select for strains carrying integrated 
antibiotic resistance genes.
 DNA Preparation, Manipulations and Hybridization  
 The methods used for the isolation and manipulation of DNA 
for  E. coli  and actinomycetes were described by Sambrook et al. 
[1989] and Kieser et al. [2000], respectively. PCR fragments were 
 Shawky  /Puk  /Wietzorrek  /Pelzer  /
Takano  /Wohlleben  /Stegmann  
J Mol Microbiol Biotechnol 2007;13:76–8886
isolated from agarose gels with a QIAquick kit (Qiagen, Hilden, 
Germany). Restriction endonucleases were obtained from various 
suppliers and were used according to their specifications. South-
ern hybridization was carried out as previously described [Pelzer 
et al., 1999].
 PCR Protocols  
 PCR was performed with a programmable thermal controller 
(MJ Research, Inc.). Each PCR mixture (100   l) contained 
100 pmol of each primer, 1.0   g of template DNA (cosmid 16.1 
or cosmid 55.1), deoxyribonucleoside 5  -triphosphates at a final 
concentration (each) of 20   M (DNA polymerization mix; Phar-
macia), 10 ! reaction buffer (Qiagen), 5 ! Q-solution (Qiagen), 
and 3.5 U of  Taq DNA polymerase. Dimethyl sulfoxide (Stra-
tagene) was added to the reaction mixture at a final concentra-
tion of 3% to enhance the specificity of hybridization. For ampli-
fication of the DNA fragments, the following PCR conditions 
were used: initial denaturation (95  °  C for 2 min); 25 cycles of 
 denaturation (95  °  C for 30 s), annealing (52  °  C for 30 s), and po-
lymerization (72  °  C for 30 s), and an additional polymerization 
step (72  °  C for 7 min) at the end. The primers used are listed in 
 table 1 .
 Expression and Purification of His 6 -Tagged Bbr 
 bbr from  A. balhimycina was amplified by PCR with the prim-
ers bbrHIS1 and bbrHIS2 ( table 1 ) that include  Bgl II and  Hin dIII 
sites, and cloned in pJOE890  Sma I blunt end. Then  bbr was cloned 
into the expression vector pRSETB (Invitrogen)  Bam HI/ Hin dIII 
to generate an in-frame fusion with the His 6 -tag (T7 promoter). 
His 6 -tagged Bbr was expressed in  E. coli BL21(DE3)pLysS cells 
and purified with nickel (II)-nitrilotriacetic acid (Ni-NTA) spin 
columns (Qiagen) at 4  °  C as described in the Ni-NTA Handbook 
(Qiagen). The starting point of purification was the soluble pro-
tein fraction of a 50-ml expression culture (induced with 1 m M 
IPTG/37  °  C) obtained after French Press and centrifugation of the 
cell lysate.
 Protein Analysis 
 Protein concentrations were determined by the Bradford 
method [Bradford, 1976] using bovine serum albumin as a stan-
dard. SDS-polyacrylamide  gel electrophoresis was carried out ac-
cording to the method of  Laemmli [1970], and protein bands were 
stained with Coomassie  Brilliant Blue G-250.
 Preparation of 3  -End DIG-Labeled DNA Fragments 
 DNA fragments were amplified from the upstream regions of 
almost all genes of the balhimycin biosynthetic gene cluster. 
Primers used for amplification of the DNA fragments are listed 
in  table 1 ; each primer pair carries the name of the corresponding 
gene. After purification, the 3  -end DIG-11-ddUTP labeling of the 
DNA fragments was carried out using DIG Gel Shift Kit, 2nd Gen-
eration (Roche Molecular Biochemicals) according to the manu-
facturer’s instructions.
 Gel Retardation Assays 
 Gel retardation assays were performed using the DIG Gel Shift 
Kit, 2nd Generation (Roche Molecular Biochemicals) according 
to the manufacturer’s instructions. 3 ng of DIG-labeled DNA 
fragment and approximately 0.2   g of partially purified His 6  
tagged Bbr, fraction eluted with 200 and 500 m M imidazole, were 
used for each assay. For testing the specificity of binding, com-
petitor plasmid-DNA or corresponding unlabeled DNA fragment 
were added in approximately 100-fold molar excess in compari-
son to the labeled fragment. After 15 min of incubation, the reac-
tion mixture was applied to a native polyacrylamide gel with 1 ! 
TBE [Sambrook et al., 1989] as running buffer. The gel was run at 
80 V for about 2 h, and transferred to a positively charged Hy-
bond-N+ nylon membrane (Amersham Biosciences) by contact 
blotting. Cross-linking and detection were carried out following 
the manufacturer’s instructions.
 Bioassay for Detection of Active Balhimycin 
 Balhimycin production was determined by bioassays using 
 Bacillus subtilis ATCC6633 as test organism and cell supernatants 
of  Amycolatopsis strains [Pelzer et al., 1999].
 Preparation of A. balhimycina RNA 
 A. balhimycina was cultivated in 100 ml of R5 medium for 
10–49 h. The cells were then harvested and shock frozen at 
–70  °  C. An aliquot was resuspended in 100   l of P buffer [Thomp-
son et al., 1982] containing 10 mg of lysozyme and then incu-
bated for 7 min at 37  °  C. The RNA was extracted by use of an 
RNeasy mini kit (Qiagen) according to the manufacturer’s in-
structions.
 RT-PCR Analysis 
 RNA prepared from  A. balhimycina was treated with 3 U of 
RNase-free DNase I (Promega, Madison, Wisc., USA) and pre-
cipitated according to standard protocols [Sambrook et al., 1989]. 
The RNA concentration was photometrically determined with a 
Genequant fixed-wavelength photometer (Pharmacia, Freiburg, 
Germany). Reverse transcription (RT) reactions were performed 
by use of an Omniscript RT kit (Qiagen) according to the manu-
facturer’s instructions. The primers used for RT reaction are list-
ed in  table 1 . PCRs were carried out in a programmable thermal 
controller (MJ Research, Inc., La Jolla, Calif., USA) under the fol-
lowing conditions: initial denaturation (95  °  C for 2 min); 25 cycles 
of denaturation (95  °  C for 20 s), annealing (60  °  C for 30 s), and 
polymerization (72  °  C for 40 s), and finally, an additional poly-
merization step (72  °  C for 7 min). Each PCR mixture (25   l) con-
tained a 1-  l aliquot of RT reaction product, 100 pmol of each 
primer, deoxyribonucleoside 5  -triphosphates at a final concen-
tration (each) of 20   M (DNA polymerization mix; Pharmacia), 
10 ! reaction buffer (Qiagen), 5 ! Q-solution (Qiagen), and 3.5 U 
of Taq DNA polymerase (Qiagen). The PCR products were ana-
lyzed by agarose gel electrophoresis (1.0%). Primers used for am-
plification are listed in  table 1 .
 Computer-Assisted Sequence Analysis 
 The PatScan software [D’Souza et al., 1997] and the BLAST 
program [Altschul et al., 1990] were used for analysis of inverted 
repeat patterns and for homology searches in the GeneBank da-
tabase, respectively.
 Nucleotide Sequence Accession Number 
 The nucleotide sequences of the balhimycin biosynthesis 
genes reported in this paper are available from the EMBL data 
library under accession number Y16952.
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